These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7667191)

  • 1. Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: in vivo evaluation.
    Gao ZH; Crowley WR; Shukla AJ; Johnson JR; Reger JF
    Pharm Res; 1995 Jun; 12(6):864-8. PubMed ID: 7667191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: in vitro evaluation.
    Gao ZH; Shukla AJ; Johnson JR; Crowley WR
    Pharm Res; 1995 Jun; 12(6):857-63. PubMed ID: 7667190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of long acting subcutaneous levonorgestrel (LNG) gel depot as an effective contraceptive option for cotton-top tamarins (Saguinus oedipus).
    Wheaton CJ; Savage A; Shukla A; Neiffer D; Qu W; Sun Y; Lasley BL
    Zoo Biol; 2011; 30(5):498-522. PubMed ID: 20938969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
    Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a 1-year levonorgestrel-releasing contraceptive implant: side effects, release rates, and biodegradability.
    Darney PD; Klaisle CM; Monroe SE; Cook CE; Phillips NR; Schindler A
    Fertil Steril; 1992 Jul; 58(1):137-43. PubMed ID: 1623994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids.
    Dhanaraju MD; Gopinath D; Ahmed MR; Jayakumar R; Vamsadhara C
    J Biomed Mater Res A; 2006 Jan; 76(1):63-72. PubMed ID: 16108044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation.
    Jain S; Sapre R; Tiwary AK; Jain NK
    AAPS PharmSciTech; 2005 Oct; 6(3):E513-22. PubMed ID: 16354012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
    Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
    Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel.
    Schulz M; Fussnegger B; Bodmeier R
    Eur J Pharm Biopharm; 2011 Feb; 77(2):240-8. PubMed ID: 21129483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F; Faundes A; Johansson E; Coutinho E
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels.
    Ory SJ; Hammond CB; Yancy SG; Hendren RW; Pitt CG
    Am J Obstet Gynecol; 1983 Mar; 145(5):600-5. PubMed ID: 6402933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of insulin from injectable biodegradable triblock copolymer.
    Kim YJ; Choi S; Koh JJ; Lee M; Ko KS; Kim SW
    Pharm Res; 2001 Apr; 18(4):548-50. PubMed ID: 11451045
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
    Archer DF; Maheux R; DelConte A; O'Brien FB
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol.
    Coney P; DelConte A
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):53-8. PubMed ID: 10561676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where next with long-acting steroids?
    Potts DM; Siemens AJ
    IPPF Med Bull; 1984 Jun; 18(3):2-3. PubMed ID: 12266285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.